Humankind Investments LLC Purchases 330 Shares of Teleflex Incorporated (NYSE:TFX)

Humankind Investments LLC grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 30.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,424 shares of the medical technology company’s stock after buying an additional 330 shares during the quarter. Humankind Investments LLC’s holdings in Teleflex were worth $253,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of TFX. T. Rowe Price Investment Management Inc. increased its stake in shares of Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock worth $1,098,693,000 after purchasing an additional 261,279 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Teleflex by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock worth $202,161,000 after purchasing an additional 8,307 shares during the last quarter. Cooke & Bieler LP increased its stake in shares of Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock worth $191,962,000 after purchasing an additional 195,150 shares during the last quarter. Invesco Ltd. increased its stake in shares of Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock worth $190,188,000 after purchasing an additional 347,003 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of Teleflex by 38.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company’s stock worth $105,102,000 after purchasing an additional 162,950 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Teleflex from $146.00 to $137.00 and set an “equal weight” rating for the company in a research note on Friday, May 2nd. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Truist Financial lowered their target price on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a report on Monday, May 5th. Morgan Stanley lowered their target price on shares of Teleflex from $191.00 to $173.00 and set an “overweight” rating on the stock in a report on Monday, May 5th. Finally, Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $164.63.

Teleflex Trading Down 0.9%

Shares of TFX stock opened at $125.10 on Monday. The company’s fifty day simple moving average is $133.86 and its two-hundred day simple moving average is $165.91. The stock has a market capitalization of $5.53 billion, a price-to-earnings ratio of 24.87, a PEG ratio of 1.73 and a beta of 1.17. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 1 year low of $120.06 and a 1 year high of $249.91.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts’ consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same period in the previous year, the business earned $3.21 EPS. As a group, analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.09%. Teleflex’s dividend payout ratio (DPR) is currently 42.90%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.